SPP1 and chronic kidney disease: Osteopontin (Spp1) was one of the most affected proteins and was significantly down-regulated with the BET inhibitor in CKD and control patients, suggesting super-enhancer dependency of Spp1 and sensitivity to BET inhibitors also in humans.